Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

Melissa A. Barhoover, Julie M. Hall, William F. Greenlee and Russell S. Thomas
Molecular Pharmacology February 2010, 77 (2) 195-201; DOI: https://doi.org/10.1124/mol.109.059675
Melissa A. Barhoover
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie M. Hall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William F. Greenlee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell S. Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 77 no. 2 195-201
DOI 
https://doi.org/10.1124/mol.109.059675
PubMed 
19917880

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 22, 2009
  • Accepted November 16, 2009
  • Published online January 19, 2010.

Article Versions

  • Earlier version (November 16, 2009 - 12:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Melissa A. Barhoover,
  2. Julie M. Hall,
  3. William F. Greenlee and
  4. Russell S. Thomas
  1. The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina
  1. Address correspondence to:
    Dr. Russell S. Thomas, The Hamner Institutes for Health Sciences, 6 Davis Drive, P.O. Box 12137, Research Triangle Park, NC 27709. E-mail: rthomas{at}thehamner.org
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2009 to April 2022

AbstractFullPdf
Nov 2009606
Dec 200953039
Jan 201032527130
Feb 20103364356
Mar 20101843948
Apr 20101103135
May 20101293315
Jun 20101311522
Jul 2010541215
Aug 2010701713
Sep 2010872422
Oct 2010561610
Nov 2010381225
Dec 2010551810
Jan 2011452119
Feb 20111258928
Mar 2011575237
Apr 2011333036
May 2011463731
Jun 2011273431
Jul 2011351634
Aug 2011284331
Sep 2011253514
Oct 2011271816
Nov 2011331919
Dec 2011252119
Jan 2012334424
Feb 2012325139
Mar 2012342316
Apr 2012363335
May 2012312028
Jun 2012222139
Jul 2012181128
Aug 2012192029
Sep 2012332240
Oct 2012391932
Nov 2012332138
Dec 2012412528
Jan 2013724937
Feb 2013292530
Mar 201322917
Apr 2013361221
May 2013261440
Jun 2013182330
Jul 2013181430
Aug 2013191719
Sep 201331920
Oct 2013251019
Nov 2013231612
Dec 2013191621
Jan 2014221924
Feb 2014231327
Mar 2014191520
Apr 2014211119
May 2014221629
Jun 2014211320
Jul 2014211921
Aug 2014113018
Sep 2014122328
Oct 2014232517
Nov 2014251911
Dec 2014201115
Jan 2015181010
Feb 201518915
Mar 2015271410
Apr 2015141468
May 201524913
Jun 2015211941
Jul 2015341918
Aug 2015561512
Sep 2015361710
Oct 201517126
Nov 201524929
Dec 201528138
Jan 2016211119
Feb 2016251114
Mar 2016231718
Apr 2016281713
May 201620118
Jun 201611927
Jul 2016121227
Aug 201620927
Sep 201681315
Oct 201671411
Nov 2016121915
Dec 20162156
Jan 20172257
Feb 201762617
Mar 201732311
Apr 2017399
May 201722715
Jun 20170188
Jul 20171196
Aug 20172287
Sep 20172149
Oct 20172217
Nov 20173289
Dec 201711211
Jan 20181246
Feb 201831810
Mar 20181234
Apr 20182268
May 20181207
Jun 201823114
Jul 20185127
Aug 201821611
Sep 20181155
Oct 201831125
Nov 201832023
Dec 201828128
Jan 20195035
Feb 20191432
Mar 20192836
Apr 20193847
May 20192536
Jun 201942613
Jul 20191422
Aug 20192148
Sep 20192624
Oct 20191712
Nov 20193122
Dec 2019932
Jan 20202039
Feb 20202132
Mar 20202432
Apr 20202632
May 20201633
Jun 20203428
Jul 20201301
Aug 20202048
Sep 20201742
Oct 20201635
Nov 20202000
Dec 20202113
Jan 202132813
Feb 202132108
Mar 20213462
Apr 20211442
May 20212375
Jun 20213350
Jul 20213221
Aug 20212382
Sep 20211457
Oct 20211320
Nov 2021814
Dec 20212232
Jan 20224033
Feb 20221124
Mar 20223474
Apr 20224268

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 77 (2)
Molecular Pharmacology
Vol. 77, Issue 2
1 Feb 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

Melissa A. Barhoover, Julie M. Hall, William F. Greenlee and Russell S. Thomas
Molecular Pharmacology February 1, 2010, 77 (2) 195-201; DOI: https://doi.org/10.1124/mol.109.059675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

Melissa A. Barhoover, Julie M. Hall, William F. Greenlee and Russell S. Thomas
Molecular Pharmacology February 1, 2010, 77 (2) 195-201; DOI: https://doi.org/10.1124/mol.109.059675
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • LYN Kinase and Tyrosine Kinase Inhibitors Regulate OATP1B3
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics